Summary
- Current Price
- As of today, GKOS price is $184.53, down -2.60% on
- Current Price All-Time High
- GKOS price is currently -2.88% below its historical high of $190.00 set on
- Market Cap
- GKOS current market cap is $11B, up +108.74% over the past 365 days
- Revenue
- GKOS current annual revenue is $507.44M, up +32.33% year-over-year
- Next Earnings
- The next earnings release for GKOS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Glaukos Corporation |
| Ticker | NYSE: GKOS |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | glaukos.com |
| Employees | 995 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $184.53 | |
| Price, 1D Change | -2.60% | |
| Market Cap | $11B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.83 | |
| Revenue | $507.44M | |
| Revenue, 1Y Change | +32.33% | |
| EPS | -$3.28 | |
| EPS, 1Y Change | -18.28% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$3.28 | |
| EPS Estimate | -$0.29 | N/A |
| EPS Est. Change | +91.15% | N/A |
| Revenue | $507.44M | |
| Revenue Estimate | $690.85M | N/A |
| Revenue Est. Change | +36.14% | N/A |
| Current Price | $184.53 | |
| Price Target | $195.00 | - |
| Price Tgt. Change | +5.67% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.83 | -$2.77 | -51.24% | |
| -$0.82 | -$3.28 | -302.44% | |
| -$0.29 | N/A | +91.15% | |
| $0.50 | N/A | +115.37% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $378.94M | $383.48M | +1.20% | |
| $500.10M | $507.44M | +1.47% | |
| $690.85M | N/A | +36.14% | |
| $844.58M | N/A | +66.44% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +102.60% | |
| Price, 3Y | +150.01% | |
| Market Cap, 1Y | +108.74% | |
| Market Cap, 3Y | +204.77% | |
| Revenue, 1Y | +32.33% | |
| Revenue, 3Y | +79.40% | |
| EPS, 1Y | -18.28% | |
| EPS, 3Y | -56.97% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $184.53 | |
| SMA 200 | $121.62 | |
| SMA 50 | $149.27 | |
| EMA 200 | $127.83 | |
| EMA 50 | $154.26 | |
| MACD | $10.35 | |
| Beta | 0.83 | |
| ATR | $6.98 | |
| 14-Day RSI | 74.50 | |
| 10-Day Volatility | 35.30% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $507.44M | |
| EPS | -$3.28 | |
| Gross Profit | $420.83M | |
| Gross Margin | 82.93% | |
| Operating Income | -$61.33M | |
| Operating Margin | -12.09% | |
| Net Income | -$187.69M | |
| Net Margin | -36.99% | |
| EBITDA | -$44.39M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.16 | |
| 4.69 | ||
| 4.06 | ||
| - | ||
| 4 | ||
| 23.22 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| 17.76 | ||
| 15.95 | ||
| -328.76 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $656.16M | |
| $278.76M | ||
| $930.37M | ||
| $474.98M | ||
| $274.22M | ||
| $101.28M | ||
| Total Debt | $103.88M | |
| $2.67M | ||
| $24.62M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $695.13M | ||
| $482.16M | ||
| $86.61M | ||
| $0.00 | ||
| $42.35M | ||
| $0.00 | ||
| -$5.35M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$14.79M | ||
| -$77.61M | ||
| $11.89M | ||
| Capex | $24.27M | |
| -$39.06M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wells Fargo | → | |
| UBS | → | |
| Truist Securities | → | |
| Stifel | → | |
| Piper Sandler | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| Citigroup | → | |
| BTIG | → | |
| Stifel | → |
Analyst sentiment
Institutional ownership
No data
Screeners with GKOS
FAQ
- What is the ticker symbol for Glaukos Corporation?
- The ticker symbol for Glaukos Corporation is NYSE:GKOS
- Does Glaukos Corporation pay dividends?
- No, Glaukos Corporation does not pay dividends
- What sector is Glaukos Corporation in?
- Glaukos Corporation is in the Healthcare sector
- What industry is Glaukos Corporation in?
- Glaukos Corporation is in the Medical Devices industry
- What country is Glaukos Corporation based in?
- Glaukos Corporation is headquartered in United States
- When did Glaukos Corporation go public?
- Glaukos Corporation initial public offering (IPO) was on June 25, 2015
- Is Glaukos Corporation in the S&P 500?
- No, Glaukos Corporation is not included in the S&P 500 index
- Is Glaukos Corporation in the NASDAQ 100?
- No, Glaukos Corporation is not included in the NASDAQ 100 index
- Is Glaukos Corporation in the Dow Jones?
- No, Glaukos Corporation is not included in the Dow Jones index
- When was Glaukos Corporation last earnings report?
- Glaukos Corporation's most recent earnings report was on July 29, 2026
- When does Glaukos Corporation report earnings?
- The next expected earnings date for Glaukos Corporation is October 28, 2026
Data Sources & References
- GKOS Official Website www.glaukos.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1192448/000119312526061944/0001193125-26-061944-index.htm
- GKOS Profile on Yahoo Finance finance.yahoo.com/quote/GKOS
- GKOS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gkos